Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer

被引:100
|
作者
Ronneberg, Jo Anders [2 ,3 ]
Fleischer, Thomas [2 ,3 ]
Solvang, Hiroko Kato [2 ]
Nordgard, Silje H. [2 ]
Edvardsen, Hege [2 ]
Potapenko, Ivan [2 ]
Nebdal, Daniel [2 ]
Daviaud, Christian [4 ]
Gut, Ivo [4 ]
Bukholm, Ida [5 ]
Naume, Bjorn [7 ]
Borresen-Dale, Anne-Lise [2 ,3 ]
Tost, Joerg [4 ]
Kristensen, Vessela [1 ,2 ,3 ,6 ]
机构
[1] Dept Clin Mol Biol Epi Gen, Lorenskog, Norway
[2] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway
[3] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway
[4] CEA, Inst Genom, Ctr Natl Genotypage, Lab Epigenet, F-91000 Evry, France
[5] Akershus Univ Hosp, Dept Surg, Nordbyhagen, Norway
[6] Univ Oslo, Fac Med, Inst Clin Epidemiol & Mol Biol EpiGen, N-0316 Oslo, Norway
[7] Oslo Univ Hosp Radiumhosp, Canc Clin, N-0310 Oslo, Norway
关键词
Breast cancer; DNA methylation; Homeobox genes; TP53; Epigenetics; Molecular classification; Gene expression; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; BONE-MARROW; DNA HYPERMETHYLATION; MOLECULAR SUBTYPES; PROGNOSTIC-FACTORS; EPITHELIAL-CELLS; OSTEOPONTIN; EPIGENETICS; PROGRESSION;
D O I
10.1016/j.molonc.2010.11.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a heterogeneous disease that can be divided in subtypes based on histology, gene expression profiles as well as differences in genomic aberrations. Distinct global DNA methylation profiles have been reported in normal breast epithelial cells as well as in breast tumors. However, the influence of the tumor methylome on the previously described subgroups of breast cancer is not fully understood. Here we report the DNA methylation profiles of 80 breast tumors using a panel of 807 cancer related genes interrogating 1505 CpG sites. We identified three major clusters based on the methylation profiles; one consisting of mainly tumors of myoepithelial origin and two other clusters with tumors of predominantly luminal epithelial origin. The clusters were different with respect to estrogen receptor status, TP53 status, ErbB2 status and grade. The most significantly differentially methylated genes including HDAC1, TFF1, OGG1, BMP3, FZD9 and HOXA11 were confirmed by pyrosequencing. Gene Ontology analysis revealed enrichment for genes involved in developmental processes including homeobox domain genes (HOXA9, HOXA11, PAX6, MYBL2, ISL1 and IPF1) and (ETS1, HDAC1, CREBBP, GAS7, SPI1 and TBX1). Extensive correlation to mRNA expression was observed. Pathway analyses identified a significant association with canonical (curated) pathways such as hepatic fibrosis including genes like EGF, NGFR and TNF, dendritic cell maturation and the NF-KB signaling pathway. Our results show that breast tumor expression subtypes harbor major epigenetic differences and tumors with similar gene expression profiles might belong to epigenetically different subtypes. Some of the transcription factors identified, with key roles in differentiation and development might play a role in inducing and maintaining the different phenotypes. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 76
页数:16
相关论文
共 50 条
  • [31] Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information
    Feeley, Linda P.
    Mulligan, Anna M.
    Pinnaduwage, Dushanthi
    Bull, Shelley B.
    Andrulis, Irene L.
    MODERN PATHOLOGY, 2014, 27 (04) : 554 - 561
  • [32] TP53 germline mutation testing in early onset breast cancer
    Conte, B.
    Varesco, L.
    Iacono, G.
    Poggio, F.
    Blondeaux, E.
    Levaggi, A.
    D'Alonzo, A.
    Bighin, C.
    Giraudi, S.
    Vaglica, M.
    Pronzato, P.
    Del Mastro, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
    Barekati, Zeinab
    Radpour, Ramin
    Kohler, Corina
    Zhang, Bei
    Toniolo, Paolo
    Lenner, Per
    Lv, Qing
    Zheng, Hong
    Zhong, Xiao Yan
    HUMAN MOLECULAR GENETICS, 2010, 19 (15) : 2936 - 2946
  • [34] Quantification of estrogen receptor α and β expression in sporadic breast cancer
    Ivan Bièche
    Béatrice Parfait
    Ingrid Laurendeau
    Igor Girault
    Michel Vidaud
    Rosette Lidereau
    Oncogene, 2001, 20 : 8109 - 8115
  • [35] Apparently "BRCA-Related" Breast and Ovarian Cancer Patient With Germline TP53 Mutation
    Janavicius, Ramunas
    Andrekute, Kristina
    Mickys, Ugnius
    Rudaitis, Vilius
    Brasiuniene, Birute
    Griskevicius, Laimonas
    BREAST JOURNAL, 2011, 17 (04): : 409 - 415
  • [36] Quantification of estrogen receptor α and β expression in sporadic breast cancer
    Bièche, I
    Parfait, B
    Laurendeau, I
    Girault, I
    Vidaud, M
    Lidereau, R
    ONCOGENE, 2001, 20 (56) : 8109 - 8115
  • [37] Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases
    Sadzeviciene, Ieva
    Snipaitiene, Kristina
    Scesnaite-Jerdiakova, Asta
    Daniunaite, Kristina
    Sabaliauskaite, Rasa
    Laurinaviciene, Aida
    Drobniene, Monika
    Ostapenko, Valerijus
    Jarmalaite, Sonata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [38] Concordance of p53 Immunohistochemistry and TP53 Mutation Status in Endometrial Cancer
    Paula, Arnaud Da Cruz
    DeLair, Deborah
    Fix, Daniel
    Soslow, Robert
    Park, Kay
    Chiang, Sarah
    Reis-Filho, Jorge
    Zehir, Ahmet
    Murali, Rajmohan
    Makker, Vicky
    Cadoo, Karen
    Mueller, Jennifer
    Leitao, Mario
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Weigelt, Britta
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1034 - 1035
  • [39] Concordance of p53 Immunohistochemistry and TP53 Mutation Status in Endometrial Cancer
    Paula, Arnaud Da Cruz
    DeLair, Deborah
    Fix, Daniel
    Soslow, Robert
    Park, Kay
    Chiang, Sarah
    Reis-Filho, Jorge
    Zehir, Ahmet
    Murali, Rajmohan
    Makker, Vicky
    Cadoo, Karen
    Mueller, Jennifer
    Leitao, Mario
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Weigelt, Britta
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1034 - 1035
  • [40] Prognostic value of mutations in TP53 and RAS genes in breast cancer
    Guerra, E
    Vacca, G
    Palombo, B
    Alberti, S
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (01): : 49 - 53